Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.
about
Clinical utility of serum biomarkers in Duchenne muscular dystrophyProteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urineIdentification of serum protein biomarkers for utrophin based DMD therapy.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.Serum proteomic assessment of the progression of fracture healing.226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.Chemotherapy-induced differential cell cycle arrest in B cell lymphomas affects their sensitivity to Wee1 inhibition.Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy.Stability and reproducibility of proteomic profiles measured with an aptamer-based platform.Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies
P2860
Q26751261-9ACB5173-7E5F-48C0-A747-ABC66AAFF457Q33675040-B9DDB529-117B-4AF0-85C0-1FF759C476DAQ37518858-78CFA37D-FA26-4ABD-84E5-07A10657F5B3Q37676311-C8B669B6-CA7B-40EB-8392-A403452E877EQ38850056-92F77606-52F8-4AB3-9953-68C65DDD2C4EQ42363358-E7646C1F-CCB5-412A-A1B2-29B14667470FQ47103310-58BDDFB8-5F90-46C5-A666-63B7F2AB33BEQ47710810-AB3F0C6E-ADDA-4EB4-AF42-E2A559D73EFAQ48543939-2CC277F7-BFAE-4999-B54F-BF71608C4A5FQ50019659-2D81C41E-998A-45EF-808B-D15241A3798AQ50020989-7D91E050-19A8-43B2-95C0-8ABFBEF63DA3Q54965928-082D062E-C6D7-4D87-9DE7-7E25DB2AFF4AQ55178512-4F335744-3480-4267-B8C0-02321A72248DQ57831005-0132ECF4-22A9-47AA-BCFA-5C7E274994EC
P2860
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Identification of novel, thera ...... ptamer-based serum proteomics.
@ast
Identification of novel, thera ...... ptamer-based serum proteomics.
@en
type
label
Identification of novel, thera ...... ptamer-based serum proteomics.
@ast
Identification of novel, thera ...... ptamer-based serum proteomics.
@en
prefLabel
Identification of novel, thera ...... ptamer-based serum proteomics.
@ast
Identification of novel, thera ...... ptamer-based serum proteomics.
@en
P2093
P2860
P356
P1433
P1476
Identification of novel, thera ...... ptamer-based serum proteomics.
@en
P2093
Alison Blain
Amer F Saleh
Corinne A Betts
Graham McClorey
Hanns Lochmüller
Michael J Gait
Raquel Manzano
Thomas C Roberts
P2860
P2888
P356
10.1038/SREP17014
P407
P577
2015-11-23T00:00:00Z